ReP USP - Resultado da busca

Filtros : "Melo Jr, Edgard Jose Franco de" Limpar

Filtros

USP affiliated authors
- campanelli, ana paula (~2)
- damante, jose humberto (~2)
- garlet, gustavo pompermaier (~2)
- silva, joão santana da (~2)
Date published
- 2011 (~1)
- 2010 (~1)
Subjects
- carcinoma de células escamosas (imunologia) (2)
- neoplasias bucais (imunologia) (2)
- imunossupressão (1)
- inflamação (1)
- linfócitos t (1)

Artigo de periodico
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma (2011)
Malaspina , Tatiana Salles de Souza; Gasparoto, Thaís Helena; Costa, Maria Renata Sales Nogueira; Melo Jr, Edgard Jose Franco de; Ikoma, Maura Rosane Valério; Damante, José Humberto; Cavassani, Karen Angélica; Garlet, Gustavo Pompermaier; Silva, João Santana da; Campanelli, Ana Paula
Source: Cancer Immunology Immunotherapy. Unidades: FOB, FMRP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS (IMUNOLOGIA), NEOPLASIAS BUCAIS (IMUNOLOGIA), LÁBIO, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALASPINA , Tatiana Salles de Souza et al. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunology Immunotherapy, v. 60, n. 7, p. 965-974, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00262-011-1007-5. Acesso em: 13 nov. 2024.
APA
Malaspina , T. S. de S., Gasparoto, T. H., Costa, M. R. S. N., Melo Jr, E. J. F. de, Ikoma, M. R. V., Damante, J. H., et al. (2011). Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Cancer Immunology Immunotherapy, 60( 7), 965-974. doi:10.1007/s00262-011-1007-5
NLM
Malaspina TS de S, Gasparoto TH, Costa MRSN, Melo Jr EJF de, Ikoma MRV, Damante JH, Cavassani KA, Garlet GP, Silva JS da, Campanelli AP. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma [Internet]. Cancer Immunology Immunotherapy. 2011 ; 60( 7): 965-974.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00262-011-1007-5
Vancouver
Malaspina TS de S, Gasparoto TH, Costa MRSN, Melo Jr EJF de, Ikoma MRV, Damante JH, Cavassani KA, Garlet GP, Silva JS da, Campanelli AP. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma [Internet]. Cancer Immunology Immunotherapy. 2011 ; 60( 7): 965-974.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00262-011-1007-5
Artigo de periodico
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment (2010)
Gasparoto, Thaís Helena; Malaspina , Tatiana Salles de Souza; Benevides, Luciana; Melo Jr, Edgard Jose Franco de; Costa, Maria Renata Sales Nogueira; Damante, José Humberto; Ikoma, Maura Rosane Valério; Garlet, Gustavo Pompermaier; Cavassani, Karen Angélica; Silva, João Santana da; Campanelli, Ana Paula
Source: Cancer Immunology Immunotherapy. Unidades: FOB, FMRP
Subjects: IMUNOSSUPRESSÃO, CARCINOMA DE CÉLULAS ESCAMOSAS (IMUNOLOGIA), LINFÓCITOS T, NEOPLASIAS BUCAIS (IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAROTO, Thaís Helena et al. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunology Immunotherapy, v. 59, n. 6, p. 819-828, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00262-009-0803-7. Acesso em: 13 nov. 2024.
APA
Gasparoto, T. H., Malaspina , T. S. de S., Benevides, L., Melo Jr, E. J. F. de, Costa, M. R. S. N., Damante, J. H., et al. (2010). Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment. Cancer Immunology Immunotherapy, 59( 6), 819-828. doi:10.1007/s00262-009-0803-7
NLM
Gasparoto TH, Malaspina TS de S, Benevides L, Melo Jr EJF de, Costa MRSN, Damante JH, Ikoma MRV, Garlet GP, Cavassani KA, Silva JS da, Campanelli AP. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment [Internet]. Cancer Immunology Immunotherapy. 2010 ; 59( 6): 819-828.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00262-009-0803-7
Vancouver
Gasparoto TH, Malaspina TS de S, Benevides L, Melo Jr EJF de, Costa MRSN, Damante JH, Ikoma MRV, Garlet GP, Cavassani KA, Silva JS da, Campanelli AP. Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment [Internet]. Cancer Immunology Immunotherapy. 2010 ; 59( 6): 819-828.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s00262-009-0803-7

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024